Twist Bioscience (TWST) Other Operating Expenses (2017 - 2026)

Twist Bioscience has disclosed Other Operating Expenses across 10 years of filings, most recently posting $53.6 million for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 14.6% year-over-year to $53.6 million; the TTM figure through Mar 2026 stood at $103.3 million (up 11.53% YoY), while the FY2023 annual figure was $5.9 million, down 58.49% from the prior year.
• Other Operating Expenses grew to $53.6 million in Q1 2026, from $49.7 million in the prior quarter.
• Over the last five years, Other Operating Expenses for TWST reached as high as $53.6 million in Q1 2026 and fell as low as -$48.8 million in Q3 2025.
• The 5-year median for Other Operating Expenses is $5.1 million (2022), against an average of $17.8 million.
• Annual changes were most pronounced in 2022 — Other Operating Expenses jumped 324.22% — and 2023, when it sank 86.27%.
• A 5-year view of Other Operating Expenses shows it stood at $4.1 million in 2022, then tumbled by 85.95% to $581000.0 in 2023, then jumped by 7795.52% to $45.9 million in 2024, then rose by 8.4% to $49.7 million in 2025, then increased by 7.78% to $53.6 million in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $53.6 million, $49.7 million, and -$48.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.